|
C12ORF32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.629900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.631600E-01 |
| Normal-vs-Stage2 |
4.543800E-01 |
| Normal-vs-Stage3 |
6.050500E-02 |
| Normal-vs-Stage4 |
8.832300E-04 |
| Stage1-vs-Stage2 |
3.445400E-01 |
| Stage1-vs-Stage3 |
5.721900E-02 |
| Stage1-vs-Stage4 |
7.232500E-04 |
| Stage2-vs-Stage3 |
2.072300E-02 |
| Stage2-vs-Stage4 |
2.640300E-04 |
| Stage3-vs-Stage4 |
1.145230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.792120E-02 |
| Normal-vs-AfricanAmerican |
7.002000E-02 |
| Normal-vs-Asian |
3.831200E-01 |
| Caucasian-vs-AfricanAmerican |
1.187780E-04 |
| Caucasian-vs-Asian |
9.682800E-01 |
| AfricanAmerican-vs-Asian |
1.148360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.303600E-02 |
| Normal-vs-Female |
2.870000E-01 |
| Male-vs-Female |
2.222200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.814390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.232590E-01 |
| Normal-vs-Age(61-80Yrs) |
9.357700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.325000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.199600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.479800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.532400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.983600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.978400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.322110E-03 |
| Normal-vs-Grade 2 |
9.909600E-01 |
| Normal-vs-Grade 3 |
6.420200E-02 |
| Normal-vs-Grade 4 |
3.598900E-04 |
| Grade 1-vs-Grade 2 |
3.559600E-04 |
| Grade 1-vs-Grade 3 |
1.93219999999883E-06 |
| Grade 1-vs-Grade 4 |
1.95160000049377E-07 |
| Grade 2-vs-Grade 3 |
3.783800E-02 |
| Grade 2-vs-Grade 4 |
2.395300E-04 |
| Grade 3-vs-Grade 4 |
1.290300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.639400E-01 |
| Normal-vs-ccB subtype |
7.995000E-04 |
| ccA subtype-vs-ccB subtype |
3.67020000002771E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.006200E-02 |
| Normal-vs-N1 |
1.058200E-02 |
| N0-vs-N1 |
1.719590E-02 |
|
|
